Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products, operating across two segments: Aflac Japan and Aflac U.S. The weighted average number of shares outstanding is 530,050,000.00 highlighting the company's shareholder base. In its Aflac Japan segment, the company offers a variety of products including cancer, medical, nursing care income support, GIFT, and both whole and term life insurance products. Additionally, it provides WAYS and child endowment plans under saving type insurance products in Japan. Meanwhile, Aflac U.S. delivers cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care, and both term and whole life insurance products in the United States. The company recorded an operating income of $4,641,000,000.00 reflecting its earnings from core operations, and the gross profit ratio is 0.39 indicating the efficiency of the company's production and sales operations. The diluted EPS is $6.83 accounting for potential share dilution, while the weighted average number of diluted shares outstanding is 532,015,000.00 reflecting potential dilution effects. Founded in 1955 and based in Columbus, Georgia, Aflac continues to be a significant presence in the insurance market. The stock is reasonably priced at $108.04 appealing to a broad range of investors. With a large market capitalization of $60,734,330,320.00 the company is a dominant player in the insurance industry, contributing significantly to the overall market landscape. The stock has a high average trading volume of 2,424,205.00 indicating strong liquidity, which supports investor confidence. Aflac belongs to the Financial Services sector, driving innovation and growth within its field. As a key player in the Insurance - Life industry, Aflac's substantial presence enhances its influence and operational strength in the market, offering investors various opportunities for engagement. Overall, Aflac embodies a robust and competitive position, reflecting its commitment to delivering value to both policyholders and shareholders alike.